[1]
N. Chitsaz, “Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica”, Curr J Neurol, vol. 18, no. 4, pp. 150-153, Aug. 2019.